The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 17 rounds in the feed, most often at Seed and in Biotech.
Corporate venture armhtgf.deRounds from 2018-07-06 to 2026-10-13
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Rabot Energy A climate tech startup turning home batteries into a virtual power plant | Series B Verified against 4 of 34 sources | $56.1M | 2026-10-13 | [ PART ] |
Today AI AI Sales Operating System for financial and insurance advisors | Seed Verified against 4 of 19 sources | $3.1M |
| 2026-10-08 |
| [ LEAD ] |
Finches A platform designed to help companies that depend on agricultural raw materials identify potential supply risks earlier | Pre-seed Verified against 4 of 33 sources | $2.2M | 2026-10-06 | [ LEAD ] |
Arcos Arcos sells cybersecurity solutions focused on protecting critical infrastructure, targeting sectors like public, commercial, and residential. | Seed Verified against 1 of 11 sources | $6.3M | 2026-09-18 | [ LEAD ] |
Jaipur Robotics A Swiss deeptech startup developing AI-powered automation for waste-to-energy plants. | Seed Developing, 2 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $4.9M | 2026-09-07 | [ LEAD ] |
Revier Therapeutics A biotech company | Seed Verified against 1 of 4 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $7.0M | 2026-08-25 | [ PART ] |
VREY A Berlin PropTech company that helps landlords enable solar power for multi-family buildings. | Seed Verified against 1 of 5 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $3.9M | 2026-04-23 | [ PART ] |
Tubulis Tubulis develops antibody-drug conjugates for treating various cancers. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $358.0M | 2025-10-15 | [ PART ] |
SRTD Biotech A biotech company focused on developing new precision mRNA therapeutics | Seed Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2024-11-14 | [ LEAD ] |
Zymofix Zymofix is a development and manufacturing partner (CDMO) that produces microorganisms at commercial scale through solid-state fermentation. | Seed Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $2.1M | 2024-11-12 | [ LEAD ] |
Tubulis Tubulis develops antibody-drug conjugates for treating various cancers. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $139.8M | 2024-03-14 | [ PART ] |
Proxima Fusion A startup commercializing stellarator fusion | Pre-seed Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $7.5M | 2023-05-30 | [ PART ] |
Rabot Energy A climate tech startup turning home batteries into a virtual power plant | Seed Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1.6M | 2023-04-18 | [ PART ] |
Tubulis Tubulis develops antibody-drug conjugates for treating various cancers. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $63.3M | 2022-05-03 | [ PART ] |
Tubulis Tubulis develops antibody-drug conjugates for treating various cancers. | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $12.2M | 2020-07-21 | [ LEAD ] |
CereGate CereGate sells a computer-brain interface platform that powers therapeutic solutions for restoring and reimagining human senses. | Convertible Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2020-01-23 | [ PART ] |
Ferroelectric-memory FMC sells high-performance, low-power ferroelectric memory solutions designed for AI applications. | Growth Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $5.4M | 2018-07-06 | [ PART ] |